Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. THIRD AMENDMENT TO...Sales Promotion and Distribution Agreement • August 3rd, 2022 • Nabriva Therapeutics PLC • Pharmaceutical preparations • New Jersey
Contract Type FiledAugust 3rd, 2022 Company Industry JurisdictionTHIRD AMENDMENT TO SALES PROMOTION AND DISTRIBUTION AGREEMENT dated as of the effective date set forth in Section 2.01 below (this “Amendment”) by and among NABRIVA THERAPEUTICS IRELAND DESIGNATED ACTIVITY COMPANY, an Irish designated activity company (“Distributor”), with its registered office at Alexandra House. Office 225/227, The Sweepstakes, Ballsbridge, Dublin 4, D04 C7H2, Ireland, MSD INTERNATIONAL GMBH, a Swiss corporation (“MSD”), with offices at Weystrasse, 20, 6006 Lucerne, Switzerland, and, solely for purposes of Sections 7.1 and 7.2 of the Agreement, MERCK SHARP & DOHME CORP., a New Jersey corporation (“Supplier”), with offices at 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.